Zacks highlights three stocks with Rank #1 buy ratings and strong growth prospects: Petco Health and Wellness (WOOF) with 26.3% earnings estimate increase, Five Below (FIVE) with 15.2% earnings growth, and Oscar Health (OSCR) with 18.8% earnings growth. All three companies feature attractive PEG ratios and strong growth scores.

Petco Health & Wellness (WOOF) and Arhaus, Inc. (ARHS) are both Retail - Miscellaneous sector stocks with Zacks Rank #1 (Strong Buy) ratings. However, WOOF presents a better value opportunity with a forward P/E of 9.33 compared to ARHS's 18.18, a PEG ratio of 0.85 versus 3.08, and a P/B ratio of 0.6 versus 3.33. WOOF earned a Value grade of A while ARHS received a C grade.

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong growth prospects: Petco Health and Wellness (WOOF) with 26.3% earnings estimate increase, Five Below (FIVE) with 15.2% earnings increase, and Oscar Health (OSCR) with 18.8% earnings increase. All three companies feature attractive PEG ratios and strong growth scores.

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong growth potential: Petco Health and Wellness (WOOF) with 26.3% earnings estimate increase, Five Below (FIVE) with 15.2% earnings increase, and Oscar Health (OSCR) with 55.1% earnings increase. All three companies feature favorable PEG ratios and strong growth scores.

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong growth prospects: Petco Health and Wellness (WOOF) with 26.3% earnings estimate increase, Five Below (FIVE) with 15.2% earnings growth, and Oscar Health (OSCR) with 63.4% earnings estimate increase over the last 60 days.

Chewy's Vet Care portfolio achieved triple-digit revenue growth in Q2, demonstrating strong customer satisfaction, veterinarian retention, and compelling clinic economics. The company expects its Health segment, including Modern Animal, to deepen customer engagement and expand wallet share as it scales. However, Chewy carries a Zacks Rank #4 (Sell) rating and has underperformed its industry by 44.7% over the past six months.

Chewy is expected to report Q2 revenues of $3.32B (+6.8% YoY) and EPS of 36 cents (+9.1% YoY) on September 9. While the company benefits from strong Autoship adoption, customer reactivation, and healthcare expansion, cautious consumer spending, tougher margin comparisons, and elevated fuel surcharges pose near-term challenges. The Zacks model does not predict an earnings beat, with the stock carrying a Zacks Rank #4 (Sell) and negative Earnings ESP of -0.61%.

In a comparison of two retail stocks, Petco Health & Wellness (WOOF) emerges as the superior value investment option compared to Ulta Beauty (ULTA). WOOF holds a Zacks Rank of #1 (Strong Buy) with a Value grade of A, featuring a forward P/E of 11.25 and P/B ratio of 0.72. ULTA, ranked #3 (Hold) with a Value grade of C, has a forward P/E of 19.50 and P/B ratio of 9.12, indicating less attractive valuation metrics.

Petco Health & Wellness reported Q2 2026 earnings of $0.16 per share, significantly beating the consensus estimate of $0.06, representing a 166.67% surprise. However, revenues of $1.49 billion slightly missed expectations by 0.3%. The stock has underperformed the S&P 500 by 19.7% year-to-date and carries a Zacks Rank #3 (Hold) rating. The Retail - Miscellaneous industry ranks in the bottom 15% of Zacks industries, which may constrain near-term performance.

Chewy is positioned as a potential 10-bagger stock following Peter Lynch's investment criteria. The company has built a differentiated pet-care ecosystem with superior customer service, telehealth offerings, and physical vet clinics. With profit growth exceeding 20%, a small market cap relative to potential, attractive valuation metrics (forward P/E of 15, PEG ratio of 0.1), and international expansion opportunities, Chewy meets Lynch's key investment requirements.

Chewy demonstrates superior growth momentum with 8% sales growth and revenue climbing to $3.3B, while Petco remains flat at $1.5B. Despite both trading at discounted valuations, Chewy's strong balance sheet, recurring Autoship revenue (84% of sales), and expansion initiatives position it as the better long-term investment compared to Petco, which carries $2.3B in debt against a $750M market cap.

Petco (WOOF) is undergoing a turnaround with improving momentum, posting positive comparable store sales of 0.7% in Q1 driven by services expansion. Despite facing intense competition from Chewy and Walmart, the company is improving margins and working to reduce debt. Analysts maintain a consensus Hold rating with 40% upside potential, though insider selling risks remain if prices strengthen significantly.